Halina Cichoż‐Lach

Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

Bruce E. Sands, Peter M. Irving, Timothy Hoops et al. · The Lancet · 2022 · 297 citations · Full text

Medicine, Clinical Sciences, Immunology +17

Genome-wide association study identifies inversion in the <i>CTRB1-CTRB2</i> locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis

Jonas Rosendahl, Holger Kirsten, Eszter Hegyi et al. · Gut · 2017 · 133 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome—A Randomized Double-Blind, Placebo-Controlled Study

Barbara Skrzydło-Radomańska, Beata Prozorow-Król, Halina Cichoż‐Lach et al. · Nutrients · 2020 · 95 citations · Full text

Life Sciences, Microbiology, Nutrition +15

The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease

Halina Cichoż‐Lach, Krzysztof Celiński, Beata Prozorow-Król et al. · Medical Science Monitor · 2012 · 84 citations · Full text

Medicine, Internal Medicine, Pathology +17

The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study

Barbara Skrzydło-Radomańska, Beata Prozorow-Król, Halina Cichoż‐Lach et al. · Nutrients · 2021 · 82 citations · Full text

Life Sciences, Microbiology, Nutritional Sciences +15